胶质瘤治疗后的影像学检查:对现有教条的挑战
本文综述胶质瘤治疗后的影像学表现,涵盖常规与先进影像技术,讨论抗血管生成药物和免疫治疗对影像表现的改变,并系统评价现有及新兴影像技术、疗效评估指南和基于人工智能的疗效评估的临床应用。
要点
- 抗血管生成药物和免疫治疗可显著改变胶质瘤治疗后影像表现,使强化、水肿和占位效应的解读困难。
- 综述涵盖常规与先进影像技术在胶质瘤治疗后评估中的表现及临床应用。
- 讨论了现有及新兴疗效评估指南和基于人工智能的疗效评估。
核心结论
- 胶质瘤治疗后影像解读具有挑战性,抗血管生成药物和免疫治疗可显著改变影像表现,使常规影像征象的解读困难;综述系统评价了现有及新兴影像技术和疗效评估指南。
研究设计与样本
- 综述,系统评价胶质瘤治疗后常规与先进影像技术的表现及临床应用,包括疗效评估指南和基于人工智能的疗效评估。
关键影像表现/征象
- 抗血管生成药物和免疫治疗可显著改变胶质瘤治疗后的影像表现。
- 上述治疗使对比强化、水肿和占位效应等常规影像征象难以解读。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Gliomas are the commonest malignant central nervous system tumours in adults and imaging is the cornerstone of diagnosis, treatment, and post-treatment follow-up of these patients. With the ever-evolving treatment strategies post-treatment imaging and interpretation in glioma remains challenging, more so with the advent of anti-angiogenic drugs and immunotherapy, which can significantly alter the appearance in this setting, thus making interpretation of routine imaging findings such as contrast enhancement, oedema, and mass effect difficult to interpret. This review details the various methods of management of glioma including the upcoming novel therapies and their impact on imaging findings, with a comprehensive description of the imaging findings in conventional and advanced imaging techniques. A systematic appraisal for the existing and emerging techniques of imaging in these settings and their clinical application including various response assessment guidelines and artificial intelligence based response assessment will also be discussed.
引用
- Bhattacharya K, Rastogi S, Mahajan A, et al. Post-treatment imaging of gliomas: challenging the existing dogmas. Clin Radiol. 2023. PMID: 38123395. doi:10.1016/j.crad.2023.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。